BioNTech delivered an unexpected financial performance in its third quarter, yet market participants remain unconvinced about ...

MAINZ, Germany, February 2, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced construction completion of the Company’s first proprietary plasmid DNA manufacturing facility ...

On slide three, you can find the agenda for today's call. Today, I'm joined by the following members of BioNTech's management team: Ugur Sahin, Chief Executive Officer and Co-Founder; Ozlem Tureci, ...

BioNTech SE (NASDAQ:BNTX) Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Welcome to BioNTech's First Quarter 2025 Earnings Call. I would like to hand the call over to Michael Horowicz, ...

The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine. "We feel that a cure for cancer or to changing cancer patients' ...

BERLIN, Oct 30 (Reuters) - BioNTech (22UAy.F), opens new tab, Chief Executive Ugur Sahin expects efficacy results from its late-stage trial of its potential coronavirus vaccine to be available shortly ...

Says high antibody levels tend not to peter out fast Says for now vaccine can last 5 days in fridge For longer storage, needs -70 degrees C December data may allow for longer fridge storage FRANKFURT, ...

Welcome to BioNTech's Fourth Quarter and Full-Year 2024 Earnings Call. I would like to hand the call over to Michael Horowicz, Director of Investor Relations. Please go ahead. Thank you. Good morning ...